Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Pharma must go further with its collaborations

May 8, 2009 Research and Development, Sales and Marketing pwC, strategy

Pharma companies will soon have to start collaborating with companies outside the healthcare sector.The global economic situation will make this …
News

Servier signs drug discovery deal with Vernalis

May 7, 2009 Research and Development, Sales and Marketing Servier, Vernalis

Servier, France's largest privately-owned pharma company, has signed a new three-year drug discovery deal with Vernalis focused on oncology. UK …
News

NICE rejects Nexavar for liver cancer

May 7, 2009 Research and Development, Sales and Marketing Bayer, NICE, Nexavar

NICE has rejected Nexavar as a treatment for liver cancer, saying it is not a cost-effective use of NHS resources. …
News

Novo Nordisk plans summer launches for new diabetes drug

May 7, 2009 Research and Development, Sales and Marketing Novo Nordisk, Victoza, diabetes

Novo Nordisk is preparing Victoza for a summer launch into its first European markets, including the UK, after it was …
News

NHS should be ‘jewel in the crown’ for UK biotech

May 7, 2009 Research and Development NICE

The NHS could be the 'jewel in the crown' of UK medical research, if it would only assist in clinical …
News

Bayer Schering’s contraceptive patch enters phase III

May 5, 2009 Research and Development, Sales and Marketing Bayer, sexual health

Bayer Schering is to start phase III trials of its new contraceptive patch and anticipates submitting the product for regulatory …
News

Coast first casualty in US overhaul of IRB system

May 5, 2009 Research and Development FDA, US

A US company offering institutional review board services to sponsors of clinical trials has been forced to close its doors …
News

Biotech partnering in the credit crunch

May 1, 2009 Research and Development biotech, partnering, pharma

Action Pharma’s Torben Jung Laursen explores the new challenges facing pharma-biotech partnering as a result of the economic downturn.In today’s …
Feature

Avastin fails in colon cancer study

April 30, 2009 Research and Development Cancer, Roche

Roche's blockbuster Avastin has failed to show success in treating early-stage colon cancer. A phase III trial found Avastin (bevacizumab) …
News

Sanofi makes cuts to phase III pipeline

April 30, 2009 Research and Development Sanofi-Aventis

Sanofi-Aventis has suspended development of four late-stage drugs and ten other projects following an R&D review. The decision was announced …
News

NICE could ease QALY to boost innovation

April 30, 2009 Research and Development NICE

NICE could be set to dramatically change its cost-effectiveness measure and help boost innovation in the UK, according to Sir …
News

Minister thanks pharma for help in swine flu fight

April 30, 2009 Research and Development h1n1

Health secretary Alan Johnson kept an appointment to address the ABPI's annual conference yesterday despite the spread of swine flu …
News

Developing health, developing profits

April 30, 2009 Research and Development, Sales and Marketing Pfizer, healthcare, working poor

Pfizer's Dr Ponni Subbiah is at the forefront of a revolution in the way the pharma industry views its business, …
Feature

Nexavar fails in melanoma study

April 30, 2009 Research and Development Bayer, Cancer, Nexavar

Onyx Pharmaceuticals and its development partner Bayer have stopped a phase II trial of Nexavar in patients with late-stage melanoma, …
News

Microdosing shows its mettle in cancer study

April 29, 2009 Research and Development Microdosing

Newly-released data has added additional weight to the evidence for microdosing studies as a means to predict whether or not …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026